Submit Feedback
Abbott Laboratories's CEO salary and other executives compensation in 2025 was as follows:
CEO/ Executive salary tells one part of the story. Explore Employee Count Trend, Revenue per Employee, and Profit per Employee to understand workforce scale, and employee productivity.
Robert B. Ford , Chairman of the Board and Chief Executive Officer, at Abbott Laboratories, received $1.50 M in base salary, $8.79 M in stock award, and $3.15 M in other compensation, making $24.20 M in total compensation in 2025.
The total compensation was +6.24% up from the previous year, 2024.
Philip P. Boudreau , Executive Vice President, Finance and Chief Financial Officer, at Abbott Laboratories, received $974.23 K in base salary, $3.05 M in stock award, and $968.72 K in other compensation, making $9.09 M in total compensation in 2025.
The total compensation was +10.51% up from the previous year, 2024.
Lisa D. Earnhardt , Executive Vice President and Group President, Medical Devices, at Abbott Laboratories, received $924.23 K in base salary, $2.54 M in stock award, and $773.74 K in other compensation, making $8.07 M in total compensation in 2025.
The total compensation was +23.04% up from the previous year, 2024.
Hubert L. Allen , Former Executive Vice President, General Counsel and Secretary, at Abbott Laboratories, received $524.02 K in base salary, $2.10 M in stock award, and $1.83 M in other compensation, making $7.00 M in total compensation in 2025.
The total compensation was -12.35% down from the previous year, 2024.
Christopher J. Scoggins , Executive Vice President, Diabetes Care, at Abbott Laboratories, received $859.50 K in base salary, $1.66 M in stock award, and $1.32 M in other compensation, making $6.60 M in total compensation in 2025.
Daniel G. Salvadori , Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products, at Abbott Laboratories, received $924.23 K in base salary, $2.24 M in stock award, and $744.02 K in other compensation, making $6.53 M in total compensation in 2025.
The total compensation was +12.86% up from the previous year, 2024.
| Executive | 2025 | 2024 | 2023 |
|---|---|---|---|
|
Robert B. Ford , Chairman of the Board and Chief Executive Officer
|
$24.20 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | $1.50 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | $1.97 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | $3.15 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | $8.79 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
|
Philip P. Boudreau , Executive Vice President, Finance and Chief Financial Officer
|
$9.09 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | $974.23 K | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | $1.06 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | $968.72 K | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | $3.05 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
|
Lisa D. Earnhardt , Executive Vice President and Group President, Medical Devices
|
$8.07 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | $924.23 K | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | $1.28 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | $773.74 K | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | $2.54 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
|
Hubert L. Allen , Former Executive Vice President, General Counsel and Secretary
|
$7.00 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | $524.02 K | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | $447.50 K | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | $1.83 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | $2.10 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
|
Christopher J. Scoggins , Executive Vice President, Diabetes Care
|
$6.60 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | $859.50 K | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | $1.10 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | $1.32 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | $1.66 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
|
Daniel G. Salvadori , Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products
|
$6.53 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | $924.23 K | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | $388.20 K | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | $744.02 K | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | $2.24 M | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
|
Robert B. Ford, Chairman of the Board and Chief Executive Officer
|
- | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
|
Robert E. Funck, Jr. Former Executive Vice President, Finance
|
- | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
|
Philip P. Boudreau, Executive Vice President, Finance and Chief Financial Officer
|
- | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
|
Hubert L. Allen, Executive Vice President, General Counsel and Secretary
|
- | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
|
Lisa D. Earnhardt, Executive Vice President and Group President, Medical Devices
|
- | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
|
Daniel G. Salvadori, Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products
|
- | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
|
Robert E. Funck, Jr., Executive Vice President, Finance
|
- | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
|
Philip P. Boudreau, Senior Vice President, Finance and Chief Financial Officer
|
- | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Base Salary | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Incentive Plan Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| All Other Compensation | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
| Stock Award | - | โขโขโขโขโขโขโขโข | โขโขโขโขโขโขโขโข |
To access the data, Sign up for free
